New drug duo aims to outsmart resistant colon cancer
NCT ID NCT03446157
Summary
This study tested whether combining two targeted drugs, palbociclib and cetuximab, could help control advanced colon cancer that has spread. It involved 24 patients whose cancer had specific genetic features and who had already tried other treatments. The goal was to see if hitting the cancer with two different approaches at once could slow its growth better than standard therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLON CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Chapel Hill, North Carolina, 27599-7295, United States
Conditions
Explore the condition pages connected to this study.